These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 949890
21. Clinical microdose study of gossypol: effect on sperm motility and renal function. Frick J, Aulitzky W, Kalla NR. Contraception; 1988 Feb; 37(2):153-62. PubMed ID: 3370988 [Abstract] [Full Text] [Related]
22. [Modification of fertility of the male by antiandrogens]. Moltz L, Neumann F, Hammerstein J. Gynakologe; 1980 Mar; 13(1):18-32. PubMed ID: 6219927 [Abstract] [Full Text] [Related]
23. Cyproterone acetate: I. Microquantity releasing device of cyproterone acetate and its failure in inducing functional sterility in male rats. Chatterjee A, Ray P, Gupta M, Pal AK, Kolay AR. Andrologia; 1977 Mar; 9(1):70-3. PubMed ID: 855942 [Abstract] [Full Text] [Related]
24. Estrogen-induced sexual receptivity and localization of 3H-estradiol in brains of female mice: effects of 5 alpha-reduced androgens, progestins and cyproterone acetate. Luttge WG, Jasper TW, Gray HE, Sheets CS. Pharmacol Biochem Behav; 1977 May; 6(5):521-8. PubMed ID: 896889 [Abstract] [Full Text] [Related]
25. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production. Matsumoto AM. J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626 [Abstract] [Full Text] [Related]
26. The role of antiandrogenic action in cyproterone acetate-induced morphologic and biochemical changes in human semen. Roy S, Chatterjee S. Fertil Steril; 1979 Jul; 32(1):93-5. PubMed ID: 456634 [Abstract] [Full Text] [Related]
27. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations. Wallace EM, Gow SM, Wu FC. J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955 [Abstract] [Full Text] [Related]
28. Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns. Kuhl H, Jung C, Taubert HD. Clin Endocrinol (Oxf); 1984 Aug; 21(2):179-88. PubMed ID: 6432376 [Abstract] [Full Text] [Related]
29. [Biometric evaluation of relative DNA and histone concentration in rabbit spermatozoa following administration of cyproterone acetate. Microcytophotometric studies]. Grabski J. Ginekol Pol; 1975 Sep; 46(9):951-8. PubMed ID: 1176030 [Abstract] [Full Text] [Related]
30. Effects of cyproterone acetate with combination of testosterone enanthate on seminal characteristics, androgenicity and clinical chemistry in langur monkey. Lohiya NK, Sharma OP. Contraception; 1983 Dec; 28(6):575-86. PubMed ID: 6232111 [Abstract] [Full Text] [Related]
31. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido. Pavlou SN, Brewer K, Farley MG, Lindner J, Bastias MC, Rogers BJ, Swift LL, Rivier JE, Vale WW, Conn PM. J Clin Endocrinol Metab; 1991 Dec; 73(6):1360-9. PubMed ID: 1955518 [Abstract] [Full Text] [Related]
32. The LH and FSH responses to LH-releasing hormone (LH-RH) in girls with true precocious puberty treated with cyproterone acetate. Kauli R, Prager-Lewin R, Keret R, Laron Z. Eur J Pediatr; 1977 Jul 01; 125(3):205-12. PubMed ID: 328285 [Abstract] [Full Text] [Related]
33. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives. Porcile A, Gallardo E. Fertil Steril; 1991 May 01; 55(5):877-81. PubMed ID: 1827074 [Abstract] [Full Text] [Related]
34. Sperm motion parameters after suppression of spermatogenesis with a gonadotropin-releasing hormone antagonist plus testosterone supplementation. Bastias MC, Kamijo H, Pavlou SN. Fertil Steril; 1993 Jun 01; 59(6):1261-5. PubMed ID: 8495775 [Abstract] [Full Text] [Related]
35. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception. Behre HM, Nashan D, Hubert W, Nieschlag E. J Clin Endocrinol Metab; 1992 Jan 01; 74(1):84-90. PubMed ID: 1727833 [Abstract] [Full Text] [Related]
36. Antispermatogenic effects of tolnidamine in langur (Presbytis entellus). Lohiya NK, Ansari AS, Scorza Barcellona P. Contraception; 1991 May 01; 43(5):485-96. PubMed ID: 1914461 [Abstract] [Full Text] [Related]
37. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women. Frölich M, Lachinsky N, Moolenaar AJ. Acta Endocrinol (Copenh); 1977 Feb 01; 84(2):333-42. PubMed ID: 138326 [Abstract] [Full Text] [Related]
38. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate. Tom L, Bhasin S, Salameh W, Steiner B, Peterson M, Sokol RZ, Rivier J, Vale W, Swerdloff RS. J Clin Endocrinol Metab; 1992 Aug 01; 75(2):476-83. PubMed ID: 1639948 [Abstract] [Full Text] [Related]
39. Daily serum follicle-stimulating hormone, luteinizing hormone, and plasma testosterone and androstenedione in hirsute women with polycystic sclerotic ovaries: effects of diethylstilbestrol and norethindrone acetats. Daane TA, Dignam WJ, Frankland MV, Simmer HH, Parlow AF. Am J Obstet Gynecol; 1973 Oct 01; 117(3):392-9. PubMed ID: 4729733 [Abstract] [Full Text] [Related]
40. Administration of norethandrolone and testosterone as a contraceptive agent for men. Brenner PF, Bernstein GS, Roy S, Jecht EW, Mishell DR. Contraception; 1975 Feb 01; 11(2):193-207. PubMed ID: 1112088 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]